An analysis of patient responses to the CITAS and RINVR identified factors associated with taste alteration in patients with cancer treated with cisplatin.

Some manufacturers are now embedding CER processes within broader regulatory operating systems, integrating authoring, ...

By reducing waste, improving forecasting, and strengthening payer negotiations, these technologies are helping pharmaceutical ...